11 Analysts Assess Cigna: What You Need To Know
Portfolio Pulse from Benzinga Insights
11 analysts have evaluated Cigna (NYSE:CI) over the past three months, with a mix of bullish and somewhat bullish ratings. The average 12-month price target is $405.36, slightly up from $402.18. Cigna's financial health is strong, with impressive revenue growth, net margin, ROE, and ROA, and a favorable debt-to-equity ratio.
October 23, 2024 | 5:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cigna has received mixed analyst ratings, with a slight increase in the average price target to $405.36. The company's strong financial performance, including high revenue growth and profitability metrics, supports a positive outlook.
The article highlights a mix of bullish and somewhat bullish analyst ratings for Cigna, with a slight increase in the average price target. Cigna's strong financial metrics, such as revenue growth and profitability, support a positive short-term outlook. The company's favorable debt management further enhances investor confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100